The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin

British Journal of Ophthalmology

Volumn 86, Issue 6, 2002, Pages 646-652

  Halberstadt, M ^a   Machens, M ^a   Gahlenbek, K A ^b   Bohnke M ^a   Garweg, Justus G ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Private Practice   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; PREDNISOLONE ACETATE; STEROID;

ADULT; AGED; CELL DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA SENSIBILITY; CORNEA TRANSPLANTATION; CORNEA VASCULARIZATION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HERPES SIMPLEX KERATITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROBABILITY; PROPHYLAXIS; REVIEW; STEROID THERAPY; STROMA; TREATMENT OUTCOME; VIRUS INFECTION; VISUAL ACUITY;

ADULT; AGED; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; CORNEAL TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KERATITIS; KERATITIS, HERPETIC; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0036280102     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.86.6.646     Document Type: Review

References (63)

1. Epidemiology of ocular herpes simplex: Incidence in Rochester. Minnesota, 1950 through 1982
2. The changing mangement and improved prognosis for corneal grafting in herpes simplex keratitis
3. Penetrating keratoplasty for herpetic keratitis: Prognosis and therapeutic determinants
4. Herpes simplex virus in the eye
5. Herpetic infections with special reference to involvement of nervous system
6. Latent herpes simplex virus in spinal ganglia of mice
7. Structural changes in chronic herpetic keratitis
8. Recurrent herpes simplex after corneal transplantation in rats
9. Herpes simplex keratitis: Role of viral infection versus immune response
10. Immunology and herpetic keratitis
11. Immunity causing blindness: Five different paths to herpes stromal keratitis
12. Molecular mimicry by herpes simplex virus type-1: Autoimmune disease after viral infection
13. Penetrating keratoplasty for herpes simplex keratitis and keratokonus: Allografts rejection and survival
14. Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis
15. Recurrence and rejection rates following corneal transplantation for herpetic keratitis
16. Oral acyclovir for herpes simplex virus eye disease
17. A prospective randomised trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis
18. Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis
19. Postoperative komplikationen nach perforierender keratoplastik in herpesaugen
20. Clinical and immunohistochemical correlation of herpetic keratitis with the expression of HLA-DR antigen
21. Detection of cellular adhesion molecules in inflamed human corneas
22. Detection of HLA class I and II antigens in rejected human corneal allografts
23. Corneal preservation in organ culture
24. Transplantation and rejection of individual cell layers of the cornea
25. Herpes simplex keratitis after keratoplasty
26. Prognostic indicators of herpeic keratitis: Analysis of a five-year observation period after corneal ulceration
27. The incidence of herpetic keratitis among population
28. Prognosis and management of corneal transplantation for herpetic keratitis
29. Longterm prognosis for corneal grafting in herpes simplex keratitis
30. Efficacy of acycloguanosine (Wellcome 248u) against herpes simplex ulceration
31. Acyclovir prophylaxis for herpes simplex virus infection
32. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection: A multicentered doubleblind trial
33. Diagnosis and management of herpes simplex stromal keratitis
34. Long-term oral acyclovir therapy
35. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis
36. Acyclovir for the prevention of recurrent herpes simplex virus eye disease
37. Pharmacokinetics of oral acyclovir (Zovirax) in the eye
38. Antiviral drug sensitivity in ocular herpes simplex infection
39. Herpetic keratitis: Persistence of viral particles despite topical and systemic antiviral therapy
40. Herpes simplex kerato-uveitis and glaucoma
41. Post-penetrating keratoplasty glaucoma: Risk factors, management and visual outcome
42. Intraocular pressure after homologous penetrating keratoplasty
43. Herpetic eye disease study: A controlled trial of topical corticosteroids for herpes simplex stromal keratitis
44. Twenty five-year panorama of corneal immunology
45. Herpes virus infection of human mesadermal tissue (cornea) detected by electron microscopy
46. The unfovourable effect of topical steroid therapy on herpetic keratitis
47. Effectiness of histocompatibility matching in high-risk corneal transplantation
48. Immune privilege and immune regulation in the eye
49. The high-risk penetrating keratoplasty
50. Entwicklung der endothelzelldichte bei verwendung von frischem und organkultiviertem gewebe
51. Isolation of herpes simplex virus from the cornea in chronic stromal keratitis
52. Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis
53. Penetrating keratoplasty for herpes simplex keratitis
54. Predictive factors for endothelial cell loss after keratoplasty
55. Morphologic and functional evaluation of the endothelium of transplanted human corneas
56. Detection of viral antigen and DNA in patients with granulomotous keratitis and keratouveitis in and ex vivo
57. Human herpesviruses in the cornea
58. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition
59. Immunopathogenisis of herpetic ocular disease
60. Herpes simplex virus 1 transmission through corneal transmission
61. Graft failure in human donor corneas due to transmission of herpes simplex virus
62. Primary graft failure a clincopathologic and molecular analysis
63. Low rate shedding of HSV-1 DNA, but not infectious virus from human donor corneae into culture media